checkAd
    Startseite > Aktien > Spero Therapeutics > Nachrichten
    Spero Therapeutics Aktie
    1,5440
     
    EUR
    +1,71 %
    +0,0260 EUR
    Letzter Kurs 13.05.24 Tradegate
    1,4920
     
    EUR
    2.012 STK
    Geldkurs 08:00:19
    1,5680
     
    EUR
    1.914 STK
    Briefkurs 08:00:19
    ISIN: US84833T1034 · WKN: A2H63F · SYM: 2HA · USA

    Neueste Nachrichten

    Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024
    08.05.24 · globenewswire · Spero Therapeutics
    Fokus Aktien mit extremen Handelsvolumen am Freitag, den 03.05.2024
    03.05.24 · wO Chartvergleich · Amgen
    Fokus Aktien mit extremen Handelsvolumen am Donnerstag, den 02.05.2024
    02.05.24 · wO Chartvergleich · Ansys
    Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    01.05.24 · globenewswire · Spero Therapeutics
    Fokus Aktien mit extremen Handelsvolumen am Donnerstag, den 14.03.2024
    14.03.24 · wO Chartvergleich · RTL Group
    Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update
    13.03.24 · globenewswire · Spero Therapeutics
    Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
    06.03.24 · globenewswire · Spero Therapeutics
    Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
    28.02.24 · globenewswire · Spero Therapeutics
    Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference
    26.02.24 · globenewswire · Spero Therapeutics
    Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    31.01.24 · globenewswire · Spero Therapeutics
    Spero Therapeutics Provides Corporate Update and 2024 Outlook
    05.01.24 · globenewswire · Spero Therapeutics
    Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections
    02.01.24 · globenewswire · Spero Therapeutics